Description
A PEER-REVIEWED ARTICLE | by Mia L. Geisinger, DDS, MS
An increasing number of people are using glucagon-like peptide receptor agonists (GLP-1-RA) and glucose-dependent insulinotropic polypeptide receptor agonist (GIPR) medications for both glycemic control and weight loss. These medications are often referred to as “incretin mimetics,” and they target physiologic processes that are involved with dysglycemia, nutrient metabolism, and nutrient storage. Given the relative novelty of this drug class, it is important that dental health-care professionals understand their mechanisms of action, common side effects, and impacts on oral and overall health. This course will review the functions of GLP-1-RA and GIPR medications, their intended and side effects, and the clinical implications for care in the dental setting.
Educational objectives
Upon completion of this course, the dental professional should be able to:
Describe the mechanisms of action and rationale for use of GLP-1-RA and GIPR medications
Critically evaluate side effects of GLP-1RA and GIPR medications and their implications for dental health-care professionals
Evaluate the impact of GLP-1RA and GIPR medications on oral health, including xerostomia, halitosis, and periodontal disease
Understand the clinical implications for patients seeking dental care who are taking GLP-1-RA and GIPR medications
Quick Access Code: 22433
Photo credit: David Petrus Ibars / E+ / Getty Images
